SAN MATEO, Calif., June 10, 2024 /PRNewswire/ — Cala, the bioelectronic medicine leader, reached a major milestone: a positive Medicare Local Coverage Determination for the Cala TAPS (Transcutaneous Afferent Patterned Stimulation) Therapy for essential tremor (ET) from the Centers for Medicare & Medicaid Services (CMS): External Upper Limb Tremor Stimulator Therapy L39591. Medicare beneficiaries who qualify under the new coverage guidelines now have access to Cala TAPS therapy to treat their hand tremor.
Cala TAPS Therapy is Now Covered by Medicare for Essential Tremor Patients
Posted on June 10, 2024
Categories: ET Treatment, In the News